An Evaluation of Short-term Isoprodian Treatment in Leprosy.
- Author:
Seok Don PARK
;
Young Pio KIM
- Publication Type:Original Article ; Randomized Controlled Trial
- MeSH:
Humans;
Leprosy*;
Prothionamide;
Tablets
- From:Korean Journal of Dermatology
1977;15(3):267-277
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Twenty-three bacteriologically positive leprosy patients were randomly selected from a leprosarium, randomly divided into four treatment groups, and given vaying dosages of Isoprodian, the tablet contained INAH 175mg, Prothionamide 175mg and DDS 50 mg, for five months. Group I: Initial 1/2 tablet dose per week with 1/2 tablet increment every weeks until 12 tablets were being consumed w.